The South Korean Ministry of Food and Drug Safety has approved the first locally-developed continuous glucose monitoring device.
The CareSens Air, developed by blood glucose device maker i-SENS, is touted to be the smallest and lightest CGM device available in South Korea. It can also be used for 15 days straight and features a calibration mechanism to make readings more reliable.
Following this...
The digital healthcare business of South Korean internet company Kakao Corporation has entered into a collaboration agreement with Dexcom to set up a global digital diabetes management service.
According to a press statement, the deal combines Kakao Healthcare's capabilities in AI and software technology with Dexcom's continuous glucose monitoring (CGM) devices, Dexcom G6 and G7, which the...
SpassMed scores US FDA 510(k) for AI sepsis detection software
South Korean medical AI company SpassMed has received the United States Food and Drug Administration's 510(k) clearance for its AI-powered sepsis detection software.
The AI solution called SpassageQ has been approved as software as a medical device for identifying sepsis, anaphylaxis, and hypovolemic shock.
South Korean researchers...
An international study led by researchers at the Faculty of Dentistry of the University of Hong Kong has developed and tested a new AI model for screening gingivitis, or gum inflammation, from images inside the mouth.
FINDINGS
The study, which is one of the first to explore the use of AI in spotting gingivitis, made use of 550 gum images with varying degrees of inflammation.
Based on findings,...
Australian Pharmaceutical Industries, a wholly-owned subsidiary of ASX-listed conglomerate Wesfarmers, is buying local telehealth business InstantScripts for A$135 million ($91 million).
Founded in 2018, the online health clinic offers a range of digital services, including telehealth consultations, online prescriptions, medical certificates, blood test requests, health management plans and...
HKUST-led study combines AI, genetic info to predict Alzheimer's risk
A research team led by the Hong Kong University of Science and Technology has made an AI model that uses genetic information to predict the risk of developing Alzheimer's disease before the onset of symptoms.
The team, which includes researchers from Shenzhen Institute of Advanced Technology and University College London, as...
Diagnostics company Nutromics has raised A$11 million ($7 million) ahead of its Series A funding round later this year.
WHAT IT'S FOR
The company has been raising funds for the imminent commercialisation of its continuous diagnostic monitoring technology.
Established in 2017, Nutromics has been developing a "lab-in-a-patch," which uses DNA sensor technology to track multiple targets, such as...
Over two years since it was first acquired, GP2U Telehealth is being sold off again.
Its parent company, UK-based Doctor Care Anywhere Group, signed a share purchase agreement to sell its Australian subsidiary to My Emergency Doctor for A$3 million ($2 million).
The deal, which is still subject to shareholder approval, is expected to be completed by end June.
WHY IT MATTERS
In a media release,...
South Korean medical AI company Lunit is helping raise Sweden's cancer screening capability by partnering with one of the country's biggest private healthcare providers.
It recently signed a three-year agreement with Capio S:t Göran Hospital to supply and license its AI-powered mammography analysis software Lunit INSIGHT MMG.
According to a press release, the AI tool will enable the hospital to...
A new AI model for diagnosing sleep apnea has been developed by a research team at Seoul National University Bundang Hospital.
The deep learning model analyses cephalograms, focusing on the tongue and its surrounding structures, which are highly associated with sleep apnea.
Based on a press statement, the model was developed using head and neck x-ray image data of 5,591 patients at SNUBH. It was...
